# Study of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency

> **NCT04147936** · NA · COMPLETED · sponsor: **Axcella Health, Inc** · enrollment: 60 (actual)

## Conditions studied

- Hepatic Insufficiency

## Interventions

- **DIETARY_SUPPLEMENT:** AXA1665
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04147936
- **Lead sponsor:** Axcella Health, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-30
- **Primary completion:** 2020-05-20
- **Final completion:** 2020-06-24
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04147936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04147936, "Study of the Safety and Tolerability of AXA1665 in Subjects With Mild and Moderate Hepatic Insufficiency". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04147936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*